298 related articles for article (PubMed ID: 1556889)
1. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
2. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
[TBL] [Abstract][Full Text] [Related]
4. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
Adams SG; Hunt EJ; Charles DA; Lang AE
J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
Maloney AP; Morrison MD
J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
7. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
Witsell DL; Weissler MC; Donovan MK; Howard JF; Martinkosky SJ
Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
[TBL] [Abstract][Full Text] [Related]
8. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
[TBL] [Abstract][Full Text] [Related]
11. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
Su CY; Lai CC; Wu PY; Huang HH
Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
[TBL] [Abstract][Full Text] [Related]
13. Perceptual-acoustic relationships in spasmodic dysphonia.
Zwirner P; Murry T; Woodson GE
J Voice; 1993 Jun; 7(2):165-71. PubMed ID: 8353631
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
Paniello RC; Barlow J; Serna JS
Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
17. Increased stability of airflow following botulinum toxin injection.
Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of Parkinson's-related dysphonia.
Sewall GK; Jiang J; Ford CN
Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
[TBL] [Abstract][Full Text] [Related]
19. Effects of type II thyroplasty on adductor spasmodic dysphonia.
Sanuki T; Yumoto E; Minoda R; Kodama N
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
[TBL] [Abstract][Full Text] [Related]
20. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
Chen W; Woo P; Murry T
J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]